GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer
NCT00157573
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Interventions
DRUG:
GM-CSF, sargramostim
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]
[object Object]